Search Results - "Tojimbara, T"

Refine Results
  1. 1

    Long-Term Outcomes in Kidney Transplantation From Expanded-Criteria Donors After Circulatory Death by Tomita, Y, Tojimbara, T, Iwadoh, K, Nakajima, I, Fuchinoue, S

    Published in Transplantation proceedings (01-01-2017)
    “…Abstract The number of recipients waiting for a transplant is increasing. In Japan, there is more frequent use of organs from expanded-criteria donors (ECDs)…”
    Get full text
    Journal Article
  2. 2

    Efficacy and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase for the Treatment of Hyperuricemia in Kidney Transplant Recipients by Tojimbara, T, Nakajima, I, Yashima, J, Fuchinoue, S, Teraoka, S

    Published in Transplantation proceedings (2014)
    “…Abstract Background Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase, is a potential alternative to allopurinol for patients with…”
    Get full text
    Journal Article
  3. 3

    Improved Outcomes of Renal Transplantation from Cardiac Death Donors: A 30‐Year Single Center Experience by Tojimbara, T., Fuchinoue, S., Iwadoh, K., Koyama, I., Sannomiya, A., Kato, Y., Nanmoku, K., Kai, K., Nakajima, I., Toma, H., Teraoka, S.

    Published in American journal of transplantation (01-03-2007)
    “…Outcomes of renal transplantation from donation after cardiac death (DCD) donors over 30 years were analyzed. Between 1975 and 2004, 256 renal transplantations…”
    Get full text
    Journal Article
  4. 4

    An intraoperative fluorescent imaging system in organ transplantation by Sekijima, M., Tojimbara, T., Sato, S., Nakamura, M., Kawase, T., Kai, K., Urashima, Y., Nakajima, I., Fuchinoue, S., Teraoka, S.

    Published in Transplantation proceedings (01-09-2004)
    “…An intraoperative fluorescent imaging system (SPY system; NovadaqTechnologies, Inc, Concord, Ontario, Canada) that enables vascular surgeons to confirm the…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    Effects of Immunosuppressants on the Progression of Hepatitis C in Hepatitis C Virus-Positive Renal Transplantation and the Usefulness of Interferon Therapy by Nanmoku, K, Imaizumi, R, Tojimbara, T, Nakajima, I, Fuchinoue, S, Sakamoto, N, Watanabe, M, Teraoka, S

    Published in Transplantation proceedings (01-09-2008)
    “…Abstract Objective The purpose of this study was to analyze the effects of immunosuppressants on hepatitis C virus (HCV) replication to establish optimal…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    How Can We Increase Living Related Donor Renal Transplantations? by Nakamura, Y, Konno, O, Matsuno, N, Yokoyama, T, Kuzuoka, K, Kihara, Y, Taira, S, Jojima, Y, Akashi, I, Iwamoto, H, Hama, K, Iwahori, T, Ashizawa, T, Kubota, K, Tojimbara, T, Nakajima, I, Nagao, T

    Published in Transplantation proceedings (01-09-2008)
    “…Abstract Background In Japan, living donor renal transplantation has gained momentum due to an increased number of patients with end-stage renal disease…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Successful Third Kidney Transplantation With Intensive Immunosuppression in a Highly Sensitized Recipient by Kawase, T, Tojimbara, T, Niki, R, Akamatsu, M, Nakajima, I, Fuchinoue, S, Agishi, T, Teraoka, S

    Published in Transplantation proceedings (01-09-2008)
    “…Abstract HLA sensitization associated with previous kidney transplantation is a major drawback to retransplantation. Recently we successfully performed a third…”
    Get full text
    Journal Article Conference Proceeding
  8. 8

    Hand-Assisted Laparoscopic Splenectomy in ABO-Incompatible Kidney Transplant Recipients by Tojimbara, T, Nakajima, I, Nanmoku, K, Ishii, Y, Tonsho, M, Yashima, J, Kudo, S, Kato, Y, Kai, K, Sannomiya, A, Koyama, I, Fuchinoue, S, Teraoka, S

    Published in Transplantation proceedings (01-09-2008)
    “…Abstract Objective We perform living-related ABO-incompatible kidney transplantations to alleviate the organ shortage in our country. Splenectomy has been…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Hand-assisted laparoscopic live donor nephrectomy: Report of 100 cases by Nakajima, I., Tojimbara, T., Sato, S., Kai, K., Kawase, T., Nakamura, M., Fuchinoue, S., Teraoka, S.

    Published in Transplantation proceedings (01-09-2004)
    “…Laparoscopic live donor nephrectomy is not yet widespread in Japan. After our first hand-assisted laparoscopic live donor nephrectomy (HALapNx) in 2001, we…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Living related liver transplantation for biliary atresia with portopulmonary hypertension: Case report by Urashima, Y., Tojimbara, T., Nakajima, I., Sato, S., Nakamura, M., Kawase, T., Kai, K., Fuchinoue, S., Teraoka, S.

    Published in Transplantation proceedings (01-10-2004)
    “…Portopulmonary hypertension is a complication of end-stage liver disease that adversely affects the outcome of liver transplantation (LT). We report a case of…”
    Get full text
    Journal Article Conference Proceeding
  13. 13

    Polymyxin B-immobilized Fiber Hemoperfusion after Emergency Surgery in Patients with Chronic Renal Failure by Tojimbara, Tamotsu, Sato, Sumihiko, Nakajima, Ichiro, Fuchinoue, Shohei, Akiba, Takashi, Teraoka, Satoshi

    Published in Therapeutic apheresis and dialysis (01-08-2004)
    “…:  The purpose of this study was to evaluate the effect of direct hemoperfusion using a Polymyxin B (PMX) immobilized fiber column in septic patients with…”
    Get full text
    Journal Article
  14. 14

    Efficacy of basiliximab induction therapy in ABO-incompatible kidney transplantation: A rapid steroid withdrawal protocol by Ando, T., Tojimbara, T., Sato, S., Nakamura, M., Kawase, T., Kai, K., Nakajima, I., Fuchinoue, S., Teraoka, S.

    Published in Transplantation proceedings (01-09-2004)
    “…We have performed ABO-incompatible (ABO-i) kidney transplantation (KT) to alleviate the severe organ shortage in our country. Induction therapy with…”
    Get full text
    Journal Article Conference Proceeding
  15. 15

    Cyclosporine-Sparing Effect of Basiliximab in Renal Transplant Recipients With Mycophenolate Mofetil by Tojimbara, T., Sato, S., Koyama, I., Nanmoku, K., Sekijima, M., Tonsyo, M., Kai, K., Kato, Y., Urashima, Y., Nakajima, I., Fuchinoue, S., Teraoka, S.

    Published in Transplantation proceedings (01-03-2005)
    “…Basiliximab added to a maintenance regimen consisting of cyclosporine microemulsion and mycophenolate mofetil was studied for its effectiveness in allowing…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    Results of kidney transplantation in patients receiving MMF- or MMF and basiliximab-containing immunosuppression by Tojimbara, T., Nakajima, I., Sato, S., Nakamura, M., Kawase, T., Kai, K., Tsuda, S., Kudo, S., Fuchinoue, S., Teraoka, S.

    Published in Transplantation proceedings (01-09-2004)
    “…Mycophenolate mofetil (MMF) is a more potent immunosuppressive drug than azathioprine or mizoribine in combination with cyclosporine (CsA) and steroids…”
    Get full text
    Journal Article Conference Proceeding
  17. 17
  18. 18
  19. 19

    Liver transplantation from non–heart beating donors in rats: Influence of viscosity and temperature of initial flushing solutions on graft function by Tojimbara, T, Wicomb, W N, Garcia‐Kennedy, R, Burns, W, Hayashi, M, Collins, G, Esquivel, C O

    Published in Liver Transplantation and Surgery (01-01-1997)
    “…Background: We evaluated the effect of warm (37 degrees C) versus cold (4 degrees C) solutions as the initial flush for liver preservation from non‐heart…”
    Get full text
    Journal Article
  20. 20

    The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction by Fuchinoue, Shohei, Ishii, Yasuo, Sawada, Tokihiko, Murakami, Toru, Iwadoh, Kazuhiro, Sannomiya, Akihito, Koyama, Ichiro, Kubota, Keiichi, Tojimbara, Tamotsu, Nakajima, Ichiro, Teraoka, Satoshi

    Published in Transplantation (27-04-2011)
    “…In 2002, we introduced the anti-CD20 chimeric antibody, rituximab, for ABO-incompatible kidney transplantation (ABO-IKT). Here, we report the 5-year outcome…”
    Get full text
    Journal Article